John Johnson
Director at Xeris Biopharma Holdings; Director at Axogen; Director at Verastem. Based in Alachua, Florida.
- Rank
- 7286th of 14,644
- Companies held
- 3
- Largest holding
- XERS, 91.0% of total
- Latest SEC filing
- Jun 19, 2026
What the $12.8M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Xeris Biopharma Holdings XERS Common Stock | Directly | 707,276 | $16.51 | $11.7M | 91.0% | Form 4, Jun 4, 2026 |
| Axogen AXGN Common Stock | Directly | 14,150 | $56.47 | $799K | 6.2% | Form 4, Jun 19, 2026 |
| Verastem VSTM Common Stock | Directly | 52,666 | $6.83 | $360K | 2.8% | Form 4, May 21, 2026 |
Share counts are the amounts John Johnson reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jun 4, 2026 | Sold | XERS | 15,000 | $6.09 | $91K | View |
| May 7, 2026 | Sold | AXGN | 11,050 | $43.26 | $478K | View |
| Dec 19, 2025 | Sold | XERS | 135,400 | $7.22 | $978K | View |
| Dec 9, 2025 | Sold | AXGN | 8,545 | $29.98 | $256K | View |
| Dec 9, 2025 | Sold | AXGN | 13,141 | $29.98 | $394K | View |
| Dec 8, 2025 | Sold | AXGN | 11,891 | $31.22 | $371K | View |
| Dec 8, 2025 | Sold | AXGN | 11,802 | $31.26 | $369K | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 7283 | Harrie Schippers PRESIDENT & CFO, PACCAR. Bellevue, WA | $12.8M |
| 7284 | Alan Hoops Director, CorVel. Fort Worth, TX | $12.8M |
| 7285 | Robert Golden Director, Hanover Bancorp. Mineola, NY | $12.8M |
| 7286 | John Johnson Director, Xeris Biopharma Holdings. Alachua, FL | $12.8M |
| 7287 | Nancy Ann Deparle Director, HCA Healthcare. Nashville, TN | $12.8M |
| 7288 | Gerard H. Gifford EVP & CAO, Crown Holdings. Tampa, FL | $12.8M |
| 7289 | Dale D. Johnson Chief Comm Development Officer, Graco. Minneapolis, MN | $12.8M |
Other Xeris Biopharma Holdings insiders
All XERS insiders- Paul R. Edick$63.1MSee Remarks. #2158 overall
- John Patrick Shannon Jr.$47.9MSee Remarks. #2633 overall
- Kevin McCulloch$26.2MSee Remarks. #4223 overall
- Steven Pieper$22.2MSee Remarks. #4789 overall
- Beth Hecht$17.9MSee Remarks. #5637 overall
- Steven Prestrelski$11.9MChief Scientific Officer. #7724 overall
Questions
How much stock does John Johnson own?
John Johnson holds $12,835,886 in listed stock based on SEC filings and current prices, mostly Xeris Biopharma Holdings (XERS). That ranks 7286th on the Stock Rich List.
Is this John Johnson's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did John Johnson last buy or sell stock?
The most recent open-market trade on file is a sale of 15,000 XERS shares on Jun 4, 2026 at $6.09.